[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.167.149.128. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 209
Citations 0
Comment & Response
September 2013

A Variant of AESOP Syndrome (Adenopathy and Extensive Skin Patch Overlying a Plasmacytoma)—Reply

Author Affiliations
  • 1Department of Dermatology, University of Utah, Salt Lake City
JAMA Dermatol. 2013;149(9):1118. doi:10.1001/jamadermatol.2013.4776

In Reply We thank you for your letter and interest in our report of a patient with a variant of the AESOP syndrome.1 The histologic features of the cutaneous manifestation of AESOP syndrome alone are nondiagnostic. Our patient’s cutaneous lesions and lymphadenopathy are consistent with the clinical features of AESOP syndrome, and they resolved with treatment of the underlying malignant neoplasm. As you have mentioned, the underlying neoplasm in this case was a Ewing sarcomalike malignant blue-cell tumor, which, unlike plasmacytoma, may result in production of different cytokines, leading to a variation in the histopathologic findings of the cutaneous lesion. While there are certain histologic features that may raise the question of a multinucleated-cell angiohistiocytoma, those lesions tend to manifest in acral locations and are not associated with an underlying malignant neoplasm, unlike that in our case, which had the clinical features consistent with a variant of the AESOP syndrome.

First Page Preview View Large
First page PDF preview
First page PDF preview
×